Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. Reply

Steven R. Ytterberg, Deepak L. Bhatt, Carol A. Connell

Research output: Contribution to journal › Letter › peer-review

25 Scopus citations

Original language	English
Pages (from-to)	1768
Number of pages	1
Journal	New England Journal of Medicine
Volume	386
Issue number	18
DOIs	https://doi.org/10.1056/NEJMc2202778
State	Published - 5 May 2022
Externally published	Yes

Access to Document

@article{c6c4a6ae23e44d7a9a28a9b98139d609,

title = "Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. Reply",

author = "Ytterberg, {Steven R.} and Bhatt, {Deepak L.} and Connell, {Carol A.}",

year = "2022",

month = may,

day = "5",

doi = "10.1056/NEJMc2202778",

language = "English",

volume = "386",

pages = "1768",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "18",

}

TY - JOUR

T1 - Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. Reply

AU - Ytterberg, Steven R.

AU - Bhatt, Deepak L.

AU - Connell, Carol A.

PY - 2022/5/5

Y1 - 2022/5/5

UR - http://www.scopus.com/inward/record.url?scp=85129455835&partnerID=8YFLogxK

U2 - 10.1056/NEJMc2202778

DO - 10.1056/NEJMc2202778

M3 - Letter

C2 - 35507493

AN - SCOPUS:85129455835

SN - 0028-4793

VL - 386

SP - 1768

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 18

ER -